TBX2 represses CST6 resulting in uncontrolled legumain activity to sustain breast cancer proliferation: a novel cancer-selective target pathway with therapeutic opportunities.

D’Costa, Zenobia C.; Higgins, Catherine; Ong, Chee Wee; Irwin, Gareth W.; Boyle, David; McArt, Darragh G.; McCloskey, Karen; Buckley, Niamh E.; Crawford, Nyree T.; Thiagarajan, Lalitha; Murray, James; Kennedy, Richard D.; Mulligan, Karl A.; Harkin, D. Paul; Waugh, David J.J.; Scott, Chris J.; Salto-Tellez, Manuel; Williams, Richard; Mullan, Paul B.

doi:10.18632/oncotarget.1707

Journal article 439 views

TBX2 represses CST6 resulting in uncontrolled legumain activity to sustain breast cancer proliferation: a novel cancer-selective target pathway with therapeutic opportunities.

Zenobia C. D’Costa, Catherine Higgins, Chee Wee Ong, Gareth W. Irwin, David Boyle, Darragh G. McArt, Karen McCloskey, Niamh E. Buckley, Nyree T. Crawford, Lalitha Thiagarajan, James Murray

, Richard D. Kennedy, Karl A. Mulligan, D. Paul Harkin, David J.J. Waugh, Chris J. Scott, Manuel Salto-Tellez, Richard Williams, Paul B. Mullan

Oncotarget, Volume: 5, Issue: 6, Pages: 1609 - 1620

Swansea University Author: James Murray

Full text not available from this repository: check for access using links below.

Check full text

DOI (Published version): 10.18632/oncotarget.1707

Published in:	Oncotarget
ISSN:	1949-2553
Published:	Impact Journals, LLC 2014
Online Access:	Check full text
URI:	https://cronfa.swan.ac.uk/Record/cronfa56402
Tags:	Add Tag No Tags, Be the first to tag this record!

first_indexed	2021-03-25T09:21:09Z
last_indexed	2021-03-26T04:22:20Z
id	cronfa56402
recordtype	SURis
fullrecord	<?xml version="1.0"?><rfc1807><datestamp>2021-03-25T09:21:10.6964306</datestamp><bib-version>v2</bib-version><id>56402</id><entry>2021-03-11</entry><title>TBX2 represses CST6 resulting in uncontrolled legumain activity to sustain breast cancer proliferation: a novel cancer-selective target pathway with therapeutic opportunities.</title><swanseaauthors><author><sid>12d0a585fcfe66f83c4c21c6bca3197b</sid><ORCID>0000-0002-6928-2347</ORCID><firstname>James</firstname><surname>Murray</surname><name>James Murray</name><active>true</active><ethesisStudent>false</ethesisStudent></author></swanseaauthors><date>2021-03-11</date><deptcode>BMS</deptcode><abstract/><type>Journal Article</type><journal>Oncotarget</journal><volume>5</volume><journalNumber>6</journalNumber><paginationStart>1609</paginationStart><paginationEnd>1620</paginationEnd><publisher>Impact Journals, LLC</publisher><placeOfPublication/><isbnPrint/><isbnElectronic/><issnPrint/><issnElectronic>1949-2553</issnElectronic><keywords>TBX2, CST6, LGMN, breast cancer</keywords><publishedDay>30</publishedDay><publishedMonth>3</publishedMonth><publishedYear>2014</publishedYear><publishedDate>2014-03-30</publishedDate><doi>10.18632/oncotarget.1707</doi><url/><notes/><college>COLLEGE NANME</college><department>Biomedical Sciences</department><CollegeCode>COLLEGE CODE</CollegeCode><DepartmentCode>BMS</DepartmentCode><institution>Swansea University</institution><apcterm/><lastEdited>2021-03-25T09:21:10.6964306</lastEdited><Created>2021-03-11T09:28:27.1678067</Created><path><level id="1">Faculty of Medicine, Health and Life Sciences</level><level id="2">Swansea University Medical School - Medicine</level></path><authors><author><firstname>Zenobia C.</firstname><surname>D’Costa</surname><order>1</order></author><author><firstname>Catherine</firstname><surname>Higgins</surname><order>2</order></author><author><firstname>Chee Wee</firstname><surname>Ong</surname><order>3</order></author><author><firstname>Gareth W.</firstname><surname>Irwin</surname><order>4</order></author><author><firstname>David</firstname><surname>Boyle</surname><order>5</order></author><author><firstname>Darragh G.</firstname><surname>McArt</surname><order>6</order></author><author><firstname>Karen</firstname><surname>McCloskey</surname><order>7</order></author><author><firstname>Niamh E.</firstname><surname>Buckley</surname><order>8</order></author><author><firstname>Nyree T.</firstname><surname>Crawford</surname><order>9</order></author><author><firstname>Lalitha</firstname><surname>Thiagarajan</surname><order>10</order></author><author><firstname>James</firstname><surname>Murray</surname><orcid>0000-0002-6928-2347</orcid><order>11</order></author><author><firstname>Richard D.</firstname><surname>Kennedy</surname><order>12</order></author><author><firstname>Karl A.</firstname><surname>Mulligan</surname><order>13</order></author><author><firstname>D. Paul</firstname><surname>Harkin</surname><order>14</order></author><author><firstname>David J.J.</firstname><surname>Waugh</surname><order>15</order></author><author><firstname>Chris J.</firstname><surname>Scott</surname><order>16</order></author><author><firstname>Manuel</firstname><surname>Salto-Tellez</surname><order>17</order></author><author><firstname>Richard</firstname><surname>Williams</surname><order>18</order></author><author><firstname>Paul B.</firstname><surname>Mullan</surname><order>19</order></author></authors><documents/><OutputDurs/></rfc1807>
spelling	2021-03-25T09:21:10.6964306 v2 56402 2021-03-11 TBX2 represses CST6 resulting in uncontrolled legumain activity to sustain breast cancer proliferation: a novel cancer-selective target pathway with therapeutic opportunities. 12d0a585fcfe66f83c4c21c6bca3197b 0000-0002-6928-2347 James Murray James Murray true false 2021-03-11 BMS Journal Article Oncotarget 5 6 1609 1620 Impact Journals, LLC 1949-2553 TBX2, CST6, LGMN, breast cancer 30 3 2014 2014-03-30 10.18632/oncotarget.1707 COLLEGE NANME Biomedical Sciences COLLEGE CODE BMS Swansea University 2021-03-25T09:21:10.6964306 2021-03-11T09:28:27.1678067 Faculty of Medicine, Health and Life Sciences Swansea University Medical School - Medicine Zenobia C. D’Costa 1 Catherine Higgins 2 Chee Wee Ong 3 Gareth W. Irwin 4 David Boyle 5 Darragh G. McArt 6 Karen McCloskey 7 Niamh E. Buckley 8 Nyree T. Crawford 9 Lalitha Thiagarajan 10 James Murray 0000-0002-6928-2347 11 Richard D. Kennedy 12 Karl A. Mulligan 13 D. Paul Harkin 14 David J.J. Waugh 15 Chris J. Scott 16 Manuel Salto-Tellez 17 Richard Williams 18 Paul B. Mullan 19
title	TBX2 represses CST6 resulting in uncontrolled legumain activity to sustain breast cancer proliferation: a novel cancer-selective target pathway with therapeutic opportunities.
spellingShingle	TBX2 represses CST6 resulting in uncontrolled legumain activity to sustain breast cancer proliferation: a novel cancer-selective target pathway with therapeutic opportunities. James Murray
title_short	TBX2 represses CST6 resulting in uncontrolled legumain activity to sustain breast cancer proliferation: a novel cancer-selective target pathway with therapeutic opportunities.
title_full	TBX2 represses CST6 resulting in uncontrolled legumain activity to sustain breast cancer proliferation: a novel cancer-selective target pathway with therapeutic opportunities.
title_fullStr	TBX2 represses CST6 resulting in uncontrolled legumain activity to sustain breast cancer proliferation: a novel cancer-selective target pathway with therapeutic opportunities.
title_full_unstemmed	TBX2 represses CST6 resulting in uncontrolled legumain activity to sustain breast cancer proliferation: a novel cancer-selective target pathway with therapeutic opportunities.
title_sort	TBX2 represses CST6 resulting in uncontrolled legumain activity to sustain breast cancer proliferation: a novel cancer-selective target pathway with therapeutic opportunities.
author_id_str_mv	12d0a585fcfe66f83c4c21c6bca3197b
author_id_fullname_str_mv	12d0a585fcfe66f83c4c21c6bca3197b_***_James Murray
author	James Murray
author2	Zenobia C. D’Costa Catherine Higgins Chee Wee Ong Gareth W. Irwin David Boyle Darragh G. McArt Karen McCloskey Niamh E. Buckley Nyree T. Crawford Lalitha Thiagarajan James Murray Richard D. Kennedy Karl A. Mulligan D. Paul Harkin David J.J. Waugh Chris J. Scott Manuel Salto-Tellez Richard Williams Paul B. Mullan
format	Journal article
container_title	Oncotarget
container_volume	5
container_issue	6
container_start_page	1609
publishDate	2014
institution	Swansea University
issn	1949-2553
doi_str_mv	10.18632/oncotarget.1707
publisher	Impact Journals, LLC
college_str	Faculty of Medicine, Health and Life Sciences
hierarchytype
hierarchy_top_id	facultyofmedicinehealthandlifesciences
hierarchy_top_title	Faculty of Medicine, Health and Life Sciences
hierarchy_parent_id	facultyofmedicinehealthandlifesciences
hierarchy_parent_title	Faculty of Medicine, Health and Life Sciences
department_str	Swansea University Medical School - Medicine{{{_:::_}}}Faculty of Medicine, Health and Life Sciences{{{_:::_}}}Swansea University Medical School - Medicine
document_store_str	0
active_str	0
published_date	2014-03-30T04:11:20Z
_version_	1763753779663994880
score	11.013148

TBX2 represses CST6 resulting in uncontrolled legumain activity to sustain breast cancer proliferation: a novel cancer-selective target pathway with therapeutic opportunities.

Similar Items